Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2009, Vol. 14 ›› Issue (11): 1258-1262.

Previous Articles     Next Articles

Comparison of inhibitory effect of five natural medicines on proliferation induced by rhbFGF in lens epithelial cell

QI Ming-xin1, ZHANG Qing-lin2, HUANG Xiu-rong2, YANG Xin2   

  1. 1Department of Ophthalmology, the Second Affiliated Hospital, 2Research Center of Pathophysiology, Fujian College of Traditional Chinese Medicine, Fuzhou 350003, Fujian, China
  • Received:2009-08-17 Revised:2009-11-16 Published:2020-10-26

Abstract: AIM: To compare the inhibitory effect of five natural medicines on proliferation induced by recombinant human basic fibroblast growth factor (rhbFGF) in lens epithelial cell (LEC). METHODS: The proliferations of cultured LEC were induced by rhbFGF, which were incubated with five natural medicines, [curcumine (Cur), elemene(Ele), arsenite trioxide (As2O3 ), triptolide (Tri) and rhizoma curcumae (Rc) ], respectively.The LEC activities were detected via methyl thiazolyl tetrazolium (MTT).The proliferating cell nuclear antigen (PCNA) of LEC were detected via flow cytometer(FCM). RESULTS: The activity of LEC and the expression of PCNA in proliferation group were higher than those in control group (P <0.01). Compared with the proliferation group, the activity of LEC and the expression of PCNA were significantly decreased in group Cur, Ele, As2O3, Tri and Rc (P < 0.01).The inhibitory effects of Cur and Ele are the strongest.As2O3, in the middle.Tri and Rc are the weakest(P <0.01), the effects of Cur and Ele are similar. CONCLUSION: The five natural medicines can inhibit the proliferation of LEC induced by rhbFGF.Cur and Ele may become effective medicines of preventing and treating after-cataract.

Key words: curcumine, elemene, arsenite trioxide, triptolide, rhizoma curcumae, lens epithelial cell, recombinant human basic fibroblast growth factor, proliferation, after-cataract

CLC Number: